A) Corrosiveness B) Inflammability C) Biocompatibility D) Toxicity
A) To induce inflammation B) To provide a structure for cells to grow and organize C) To prevent regeneration D) To block cell growth
A) Fatigue resistance B) Chemical stability C) Thermal conductivity D) Biodegradability
A) Heavy weight B) High cost C) Corrosion D) Biocompatibility
A) Increase toxicity B) Decrease biocompatibility C) Enhanced surface interactions and properties D) Reduce mechanical strength
A) PMMA B) Silicone rubber C) Polyethylene D) Hydroxyapatite
A) Keratinocytes B) Fibroblasts C) Macrophages D) Red blood cells
A) To accelerate degradation B) To prevent infections C) To promote inflammation D) To increase toxicity
A) Marine biology B) Biomaterials science or biomaterials engineering C) Astrophysics D) Quantum mechanics
A) Biomaterials cannot be used in medical applications B) There is no difference between them C) Biological materials are always synthetic D) Biomaterials are engineered, while biological materials are naturally produced
A) Only natural fibers B) Metallic components, polymers, ceramics, or composite materials C) Exclusively organic compounds D) Pure water-based solutions
A) Through random trial and error methods B) Using only historical data without new testing C) By computational routines predicting molecular effects based on limited in vitro experimentation D) Exclusively through animal testing
A) The random distribution of particles in a solution. B) The spontaneous aggregation of particles without external forces. C) A process requiring mechanical manipulation to form structures. D) An assembly method that uses magnetic fields.
A) The chemical composition of particles. B) The external forces applied to the system. C) The spatial scale of the unit cell (lattice parameter). D) The temperature at which assembly occurs.
A) Random particle distribution. B) Self-organization. C) Chemical bonding between particles. D) External guidance and control.
A) 70 to 100 nm. B) 60 nm. C) 3 nm. D) 1.5 nm.
A) About 60/40. B) 70/30. C) 80/20. D) 50/50.
A) On the surface of tropocollagen molecules. B) At the gaps between collagen fibrils. C) Randomly throughout the matrix. D) Within the mineral phase only.
A) "Bricks" with dimensions of 0.5. B) 20 to 30 nm layers. C) 60 nm diameter canals. D) 1 μm diameter rods.
A) Collagen. B) Hydroxyapatite. C) Calcium carbonate. D) Chitin.
A) A random distribution. B) A helical pattern. C) A cubic pattern. D) An amorphous structure.
A) 60 nm. B) 70 to 100 nm. C) 20 to 30 nm. D) 1 μm.
A) ISO 27001 B) ISO 10993 C) ISO 14001 D) ISO 9001
A) Sugars B) Nucleotides C) Amino acids D) Fatty acids
A) Bone graft substitute B) Heart valve coating C) Artificial skin scaffold D) Dental filling material
A) Polyethylene terephthalate B) Pyrolytic carbon C) Calcium sulfate D) Stainless steel
A) Animal skin B) Synthetic polymers C) Metal wires D) Plant fibers
A) 20 different configurations B) 14 different configurations C) 5 different configurations D) 10 different configurations
A) Nylon B) Kevlar C) Spandex D) Dacron
A) Inflammatory reaction B) Foreign body response (FBR) C) Healing process D) Immune response
A) Molecular level B) Ultra-structure level C) Microstructure level D) Sub atomic level
A) 25% B) 60% C) 75% D) 49%
A) Non-biodegradable B) Mechanically strong C) Electrically conductive D) Chemically reactive
A) 20 to 30 nm. B) 3 nm. C) 60 nm. D) 1 μm.
A) 1.5 nm. B) 70 to 100 nm. C) 3 mm. D) Approximately 60 nm.
A) Biodegradation B) Biofabrication C) Biocompatibility D) Biomimetics
A) Early 1950s B) Later 1960s C) 1980s D) 2000s
A) Wound closure B) Tissue growth stimulation C) Drug delivery D) Bone strengthening
A) Resolution phase B) Chronic phase C) Healing phase D) Acute phase
A) Toxic B) Biocompatible C) Brittle D) Non-degradable
A) Size B) Alignment C) Shape D) Elasticity
A) Liposomes B) Silica C) Polymers D) Polyetheretherketone (PEEK)
A) Starch B) Proteins C) DNA D) Cellulose
A) Macrophages B) Neutrophils C) Eosinophils D) Lymphocytes
A) Biocompatibility B) Acute inflammation only C) Foreign body response D) Graft-versus-host disease
A) Skin repair devices B) Dental implants C) Contact lenses D) Joint replacements
A) Only the damaged tissue B) No structures are isolated C) Immune cells D) The implant
A) Cellulose B) Starch C) Silk D) DNA
A) Toxic B) Inert C) Non-biodegradable D) Biodegradable
A) Flexural rigidity B) Ductility C) Young's Modulus D) Tensile strength
A) Polypropylene (PP) B) Polyetherimide (PEI) C) Polycarbonate (PC) D) Cyclic olefin polymer (COP)
A) Elicit a strong immune reaction B) Avoid any interaction with the immune system C) Direct the immune response rather than circumvent it D) Suppress the immune response entirely
A) Toughness B) Compressive strength C) Flexural rigidity D) Elasticity
A) Aluminum B) Ceramic C) Stainless steel D) Ivory
A) X-ray Diffraction B) Nuclear Magnetic Resonance C) Mass Spectrometry D) Scanning Electron Microscopy
A) Edge dislocation B) Line defects C) Macrostructure D) Point defects |